PA-based NewSpring Secures over $180M for Fourth Growth Equity Healthcare Fund. With over 20 years of experience investing in companies that help various segments of the healthcare ecosystem transform the way patients are cared for, NewSpring Healthcare is a thesis-driven, domain-specific growth equity strategy.
Both new and current investors, including a wide range of family offices, financial institutions, and strategists, backed NSH IV. Using primary and secondary research, its team focuses on proprietary deal flow and finds industries that have an important effect on healthcare.
Read also – CA-based Hyperlink Ventures Secures it’s First fund at $32M
Prior to the final close, NSH IV has already made six investments: AeroSafe Global, a provider of specialised pharmaceutical distribution services; BetterNight, an entire sleep disorders management solution; and Cardiovascular Staffing Leader.
Healthcareworks, Patheous Health, which leads the mobile dysphagia diagnostics market; Prosperity Behaviour Health, which offers business process outsourcing services to behavioural health programmes; and Verisma, which leads the healthcare disclosure management services and technology market.
Read also – ME-based Biochar Producer Standard Biocarbon Secures $5M in Funding
Established in 1999, NewSpring oversees around $3.5 billion in five different strategies, ranging from mezzanine debt to growth equity and control buyouts.
About NewSpring
In order to generate quantifiable value for business owners and Limited Partners, NewSpring collaborates with lower-middle market companies. They strive for excellence, build strong, long-lasting relationships, and match their objectives and principles with those of business owners, financiers, and staff members.
Read also – TX-based Cart.com Secures $30M Growth Funding
